VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study

  • Julie E. Chang
  • , Lakeesha L. Carmichael
  • , Kyung Mann Kim
  • , Christopher Peterson
  • , David T. Yang
  • , Anne M. Traynor
  • , Jae E. Werndli
  • , Michael S. Huie
  • , Thomas A. McFarland
  • , Michael Volk
  • , Jules Blank
  • , Natalie S. Callander
  • , Walter L. Longo
  • , Brad S. Kahl

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e61-e67
JournalClinical Lymphoma, Myeloma and Leukemia
Volume18
Issue number1
DOIs
StatePublished - Jan 2018

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • Autologous stem cell transplant
  • Bortezomib
  • Hyper-CVAD
  • MIPI score
  • Non-Hodgkin lymphoma

Cite this